To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene STX16andNPEPL1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
619 representative clones for gene STX16andNPEPL1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BM544905 ovary (pool of 3) STX16andNPEPL1.a 1 to 619 15 to 635   tiling clone,   621/1186
(52 %)
19 diff
(98.4 %id)
CB994630 placenta, pre-eclamptic placenta STX16andNPEPL1.a 27 to 719 28 to 723       696/871
(79 %)
13 diff
(98.6 %id)
NM_024663.3   STX16andNPEPL1.a 27 to 2210 1 to 2184   RefSeq, AAA   2184/2184
(100 %)
0 diff
(100 %id)
TI_44170469   STX16andNPEPL1.a 38 to 757 83 to 803       721/803
(89 %)
8 diff
(99.1 %id)
BI552979 brain, hippocampus STX16andNPEPL1.a 39 to 757 1 to 720       720/720
(100 %)
5 diff
(99.4 %id)
CD385668 embryonic trophoblasts, made from WA01 stemcells STX16andNPEPL1.a 48 to 798 15 to 777       763/907
(84 %)
23 diff
(97.5 %id)
BC020507 Pancreas, epithelioid carcinoma STX16andNPEPL1.a 61 to 2210 1 to 2150   tiling clone, available from MGC, AAA   2150/2150
(100 %)
0 diff
(100 %id)
BG751478 eye, normal pigmented retinal epithelium STX16andNPEPL1.a 61 to 810 1 to 749       749/749
(100 %)
8 diff
(99.0 %id)
CN259749 embryonic stem cells, cell lines H1, H7, andH9 STX16andNPEPL1.a 63 to 783 1 to 722       722/722
(100 %)
3 diff
(99.6 %id)
BM546037 ovary (pool of 3) STX16andNPEPL1.a 65 to 1120 20 to 1086       1067/1174
(90 %)
49 diff
(95.9 %id)
CX166539 human embryonic stem cells differentiated toan early endodermal cell type STX16andNPEPL1.a 67 to 786 1 to 720       720/720
(100 %)
2 diff
(99.8 %id)
AK223094   STX16andNPEPL1.a 69 to 1766 1 to 1698       1698/1698
(100 %)
4 diff
(99.8 %id)
BX384274   STX16andNPEPL1.a 69 to 1017 1 to 941       941/945
(99 %)
12 diff
(98.8 %id)
TI_57147448   STX16andNPEPL1.a 69 to 866 32 to 835       802/835
(96 %)
20 diff
(97.7 %id)
BP272440   STX16andNPEPL1.a 69 to 664 1 to 595       595/597
(99 %)
13 diff
(97.9 %id)
DA386062 thalamus STX16andNPEPL1.a 70 to 628 2 to 561   capped   560/570
(98 %)
2 diff
(99.7 %id)
BI759956 pooled colon, kidney, stomach STX16andNPEPL1.a 72 to 866 1 to 801       799/801
(99 %)
19 diff
(97.7 %id)
CR607400 HeLa cells Cot 25-normalized STX16andNPEPL1.a 74 to 1746 1 to 1674       1674/1674
(100 %)
1 diff
(100.0 %id)
DA274905 corpus callosum STX16andNPEPL1.a 75 to 651 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
CN259748 embryonic stem cells, DMSO-treated H9 cellline STX16andNPEPL1.a 78 to 558 12 to 492       481/492
(97 %)
7 diff
(98.6 %id)
CF593768 Human Placenta, placenta STX16andNPEPL1.a 81 to 719 29 to 671       641/840
(76 %)
23 diff
(97.3 %id)
BE908363 epithelioid carcinoma, Pancreas STX16andNPEPL1.a 82 to 540 1 to 460       460/460
(100 %)
1 diff
(99.8 %id)
BU860055 adenocarcinoma, cell line, breast STX16andNPEPL1.a 84 to 443 1 to 363   AAA   363/930
(39 %)
5 diff
(99.5 %id)
BU955802 adenocarcinoma, cell line, breast STX16andNPEPL1.a 84 to 798 1 to 723       723/906
(79 %)
10 diff
(98.9 %id)
AK021645 whole embryo, mainly head STX16andNPEPL1.a 86 to 1777 1 to 1691   available from FLJ,   1691/1691
(100 %)
4 diff
(99.8 %id)
AU118479 whole embryo, mainly head STX16andNPEPL1.a 87 to 852 2 to 764   capped   763/764
(99 %)
8 diff
(99.0 %id)
CN259747 embryonic stem cells, DMSO-treated H9 cellline STX16andNPEPL1.a 91 to 490 1 to 401       401/401
(100 %)
3 diff
(99.3 %id)
AK315684 testis STX16andNPEPL1.a 95 to 1693 1 to 1599       1599/1599
(100 %)
3 diff
(99.9 %id)
BP295288   STX16andNPEPL1.a 95 to 673 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
DB045143 testis STX16andNPEPL1.a 96 to 643 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
DA087238 cerebellum STX16andNPEPL1.a 97 to 665 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BG772622 testis STX16andNPEPL1.a 100 to 837 1 to 741       741/743
(99 %)
14 diff
(98.2 %id)
TI_57178738   STX16andNPEPL1.a 102 to 904 64 to 861       798/861
(92 %)
22 diff
(97.5 %id)
AL556175 placenta STX16andNPEPL1.a 103 to 974 33 to 902   fully sequenced,   870/902
(96 %)
25 diff
(97.3 %id)
BI767064 pooled lung and spleen STX16andNPEPL1.a 107 to 904 1 to 793       793/793
(100 %)
17 diff
(97.9 %id)
DA873369 Prostate STX16andNPEPL1.a 107 to 678 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA371095 thalamus STX16andNPEPL1.a 114 to 685 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BI772152 pooled lung and spleen STX16andNPEPL1.a 115 to 885 1 to 771       771/771
(100 %)
11 diff
(98.6 %id)
TI_57178921   STX16andNPEPL1.a 115 to 885 30 to 800       771/800
(96 %)
17 diff
(97.9 %id)
DA426918 colon STX16andNPEPL1.a 117 to 677 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
AL547939 placenta, Placenta Cot 25-normalized STX16andNPEPL1.a 117 to 943 1 to 828       828/828
(100 %)
6 diff
(99.3 %id)
DA443626 tongue, tumor tissue STX16andNPEPL1.a 117 to 675 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB045669 testis STX16andNPEPL1.a 120 to 679 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
AL554089 placenta, Placenta Cot 25-normalized STX16andNPEPL1.a 123 to 1128 1 to 1002       1002/1096
(91 %)
16 diff
(98.6 %id)
BI260588 cervical carcinoma cell line, cervix STX16andNPEPL1.a 124 to 798 10 to 686       677/699
(96 %)
32 diff
(95.5 %id)
TI_57148583   STX16andNPEPL1.a 133 to 868 51 to 786       734/786
(93 %)
18 diff
(97.8 %id)
BI759817 pooled colon, kidney, stomach STX16andNPEPL1.a 138 to 868 1 to 731       729/731
(99 %)
12 diff
(98.4 %id)
BU589370 mixed (pool of 40 RNAs) STX16andNPEPL1.a 145 to 799 31 to 694       664/996
(66 %)
18 diff
(98.2 %id)
BI758416 brain STX16andNPEPL1.a 149 to 884 57 to 796       740/796
(92 %)
16 diff
(98.0 %id)
TI_57218472   STX16andNPEPL1.a 149 to 884 57 to 796       740/796
(92 %)
16 diff
(98.0 %id)
AL731929 breast STX16andNPEPL1.a 156 to 404 14 to 260       247/277
(89 %)
8 diff
(97.2 %id)
DA287141 corpus callosum STX16andNPEPL1.a 175 to 711 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
DN996194 breast cancer, Mammary gland (cancer tissue) STX16andNPEPL1.a 199 to 784 1 to 586       586/586
(100 %)
6 diff
(99.0 %id)
DA874834 Prostate STX16andNPEPL1.a 217 to 789 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BM711461 eye, fetal eyes STX16andNPEPL1.a 739 to 1225 9 to 495       487/495
(98 %)
7 diff
(98.6 %id)
AL578486 placenta STX16andNPEPL1.a 913 to 1723 830 to 23   fully sequenced,   808/830
(97 %)
2 diff
(99.8 %id)
AA143102 Pancreas STX16andNPEPL1.a 939 to 1153 1 to 217       217/217
(100 %)
6 diff
(97.3 %id)
AL572763 placenta, Placenta Cot 25-normalized STX16andNPEPL1.a 1160 to 2152 984 to 1       984/1018
(96 %)
24 diff
(97.7 %id)
AL576907 placenta, Placenta Cot 25-normalized STX16andNPEPL1.a 1203 to 2181 972 to 1       972/1028
(94 %)
29 diff
(97.2 %id)
AU145029 whole embryo, mainly head STX16andNPEPL1.a 1349 to 1777 429 to 1       429/429
(100 %)
1 diff
(99.8 %id)
BF967276 brain, hypothalamus STX16andNPEPL1.a 1450 to 2203 1 to 750   AAA   750/750
(100 %)
20 diff
(97.4 %id)
TI_149309186   STX16andNPEPL1.a 1461 to 2205 865 to 130       739/1044
(70 %)
15 diff
(98.6 %id)
BI524692 pooled lung and spleen STX16andNPEPL1.a 1482 to 2156 720 to 7       714/720
(99 %)
5 diff
(99.4 %id)
TI_44158695   STX16andNPEPL1.a 1482 to 2156 720 to 7       714/720
(99 %)
5 diff
(99.4 %id)
TI_149289844   STX16andNPEPL1.a 1500 to 2205 790 to 85   AAA   706/706
(100 %)
14 diff
(98.1 %id)
BU623633 cell lines, Enchondroma STX16andNPEPL1.a 1500 to 2210 729 to 19   AAA   711/711
(100 %)
5 diff
(99.3 %id)
TI_149292543   STX16andNPEPL1.a 1508 to 2209 775 to 84   AAA   694/692
(100 %)
12 diff
(98.3 %id)
BM991878 Bone, Subchondral Bone STX16andNPEPL1.a 1520 to 2210 709 to 19   AAA   691/691
(100 %)
0 diff
(100 %id)
BM974628 lung STX16andNPEPL1.a 1609 to 2209 616 to 19   AAA   598/598
(100 %)
4 diff
(99.4 %id)
BU624023 cell lines, Enchondroma STX16andNPEPL1.a 1609 to 2210 620 to 19   AAA   602/602
(100 %)
5 diff
(99.2 %id)
BU687602 lung STX16andNPEPL1.a 1619 to 2205 605 to 19   AAA   587/587
(100 %)
14 diff
(97.7 %id)
BM973005 lung STX16andNPEPL1.a 1620 to 2205 604 to 19   AAA   586/586
(100 %)
5 diff
(99.2 %id)
BU622775 cell lines, Enchondroma STX16andNPEPL1.a 1651 to 2210 576 to 19   AAA   558/564
(98 %)
7 diff
(98.8 %id)
DB484421 hypothalamus STX16andNPEPL1.a 1652 to 2083 431 to 2     Submitted on the opposite strand 430/435
(98 %)
0 diff
(100 %id)
BE675848 B-cell, chronic lymphotic leukemia STX16andNPEPL1.a 1659 to 2205 548 to 2       547/551
(99 %)
0 diff
(100 %id)
DB341757 testis STX16andNPEPL1.a 1664 to 2204 542 to 1       542/542
(100 %)
1 diff
(99.9 %id)
AI693547 pooled STX16andNPEPL1.a 1680 to 2211 532 to 1       532/532
(100 %)
3 diff
(99.5 %id)
DB575845 hypothalamus STX16andNPEPL1.a 1708 to 2204 1 to 498     Submitted on the opposite strand 498/498
(100 %)
3 diff
(99.4 %id)
AW117949 esophagus, squamous cell carcinoma STX16andNPEPL1.a 1736 to 2210 489 to 15   AAA   475/475
(100 %)
3 diff
(99.4 %id)
BI253700 cervical carcinoma cell line, cervix STX16andNPEPL1.a 1736 to 2148 1 to 412       412/412
(100 %)
3 diff
(99.3 %id)
AA778640   STX16andNPEPL1.a 1737 to 2211 476 to 4       473/476
(99 %)
0 diff
(100 %id)
DB565525 hypothalamus STX16andNPEPL1.a 1737 to 2204 1 to 468     Submitted on the opposite strand 468/468
(100 %)
3 diff
(99.4 %id)
AW468685 pooled STX16andNPEPL1.a 1741 to 2211 471 to 1       471/471
(100 %)
2 diff
(99.6 %id)
AI801370 poorly differentiated adenocarcinoma withsignet ring cell features, stomach STX16andNPEPL1.a 1744 to 2205 475 to 14   AAA   462/462
(100 %)
3 diff
(99.4 %id)
AA890730 parathyroid gland, parathyroid tumor STX16andNPEPL1.a 1754 to 2210 490 to 35   AAA   456/458
(99 %)
4 diff
(99.2 %id)
AI434131 lymph node, lymphoma, follicular mixed small and largecell STX16andNPEPL1.a 1760 to 2203 444 to 2       443/444
(99 %)
0 diff
(100 %id)
AW001899 thymus, pooled STX16andNPEPL1.a 1764 to 2211 454 to 7       448/454
(98 %)
0 diff
(100 %id)
AA573416 colon STX16andNPEPL1.a 1774 to 2210 448 to 14   AAA   435/435
(100 %)
6 diff
(98.7 %id)
BG992758 head_neck STX16andNPEPL1.a 1777 to 1952 181 to 6       176/181
(97 %)
0 diff
(100 %id)
BG988535 head_neck STX16andNPEPL1.a 1780 to 1980 16 to 215       200/215
(93 %)
8 diff
(96.3 %id)
BF508778   STX16andNPEPL1.a 1788 to 2205 435 to 18   AAA   418/428
(97 %)
2 diff
(99.6 %id)
AJ707008 heart STX16andNPEPL1.a 1791 to 2170 387 to 9     Submitted on the opposite strand 379/398
(95 %)
0 diff
(100 %id)
AA652457 normal prostate, Prostate STX16andNPEPL1.a 1803 to 2210 413 to 8       406/413
(98 %)
0 diff
(100 %id)
AI033982 parathyroid gland, parathyroid tumor STX16andNPEPL1.a 1805 to 2211 415 to 9       407/415
(98 %)
0 diff
(100 %id)
BM670712 eye, fetal eyes STX16andNPEPL1.a 1813 to 2210 417 to 19   AAA   399/399
(100 %)
3 diff
(99.3 %id)
BM686846 eye, eye anterior segment STX16andNPEPL1.a 1820 to 2210 9 to 399       391/399
(97 %)
2 diff
(99.5 %id)
BM707448 eye, eye anterior segment STX16andNPEPL1.a 1820 to 2211 9 to 400       392/403
(97 %)
3 diff
(99.3 %id)
TI_151742328   STX16andNPEPL1.a 1820 to 2210 520 to 130   AAA   391/533
(73 %)
3 diff
(99.5 %id)
AI826270 normal prostate, Prostate STX16andNPEPL1.a 1829 to 2210 411 to 30   AAA   382/382
(100 %)
17 diff
(95.6 %id)
AA918511 Kidney STX16andNPEPL1.a 1831 to 2204 372 to 1       372/372
(100 %)
4 diff
(99.0 %id)
BM673701 eye, eye anterior segment STX16andNPEPL1.a 1832 to 2210 397 to 19   AAA   379/379
(100 %)
4 diff
(99.0 %id)
AA631567 lung, lung tumor STX16andNPEPL1.a 1843 to 2203 373 to 15   AAA   359/359
(100 %)
5 diff
(98.7 %id)
F22701 pectoral muscle (after mastectomy) STX16andNPEPL1.a 1855 to 2210 1 to 356       356/357
(99 %)
7 diff
(98.1 %id)
BQ370140 placenta_normal STX16andNPEPL1.a 1857 to 1993 12 to 149       138/149
(92 %)
6 diff
(96.0 %id)
AA687760 normal prostate, Prostate STX16andNPEPL1.a 1873 to 2211 344 to 6       339/344
(98 %)
0 diff
(100 %id)
AI458156 carcinoid, lung STX16andNPEPL1.a 1879 to 2210 352 to 21   AAA   332/340
(97 %)
4 diff
(98.9 %id)
BE045477 lymph node, lymphoma, follicular mixed small and largecell STX16andNPEPL1.a 1884 to 2205 324 to 3       322/324
(99 %)
0 diff
(100 %id)
AW770290 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney STX16andNPEPL1.a 1887 to 2210 323 to 1       323/323
(100 %)
11 diff
(96.6 %id)
BX117185 ovarian tumor, ovary STX16andNPEPL1.a 1891 to 2205 11 to 325   AAA   315/325
(96 %)
6 diff
(98.2 %id)
AA394172 ovarian tumor, ovary STX16andNPEPL1.a 1892 to 1986 1 to 93   fully sequenced,   93/93
(100 %)
0 diff
(100 %id)
BM852427 stomach STX16andNPEPL1.a 1908 to 2203 1 to 296       296/296
(100 %)
1 diff
(99.7 %id)
AA292780 ovarian tumor, ovary STX16andNPEPL1.a 1956 to 2205 249 to 1   fully sequenced,   249/249
(100 %)
1 diff
(99.6 %id)
AA150391 Pancreas STX16andNPEPL1.a 2029 to 2204 175 to 1       175/175
(100 %)
4 diff
(97.8 %id)
BP232534 muscle STX16andNPEPL1.b 1 to 545 1 to 546   tiling clone,   546/582
(93 %)
21 diff
(96.4 %id)
AK307771 alzheimer cortex STX16andNPEPL1.b 5 to 1917 1 to 1912 T36R D37T S38A C39V L41S ... tiling clone,   1912/1912
(100 %)
5 diff
(99.8 %id)
DC312155 alzheimer cortex STX16andNPEPL1.b 5 to 545 1 to 540       540/546
(98 %)
5 diff
(99.1 %id)
DB494473 hypothalamus STX16andNPEPL1.b 6 to 497 1 to 492       492/492
(100 %)
5 diff
(99.0 %id)
DB504602 hypothalamus STX16andNPEPL1.b 6 to 484 1 to 479       479/479
(100 %)
7 diff
(98.6 %id)
BP277548 Kidney STX16andNPEPL1.b 14 to 481 1 to 469       469/580
(80 %)
18 diff
(96.9 %id)
CV023749 mixed STX16andNPEPL1.b 375 to 1022 1 to 645   tiling clone,   645/648
(99 %)
4 diff
(99.4 %id)
CR986658 T-Lymphocytes STX16andNPEPL1.b 402 to 1194 1 to 793       793/794
(99 %)
3 diff
(99.7 %id)
CB127946 cervix, Uterine STX16andNPEPL1.b 511 to 1033 1 to 523       523/523
(100 %)
0 diff
(100 %id)
BP203534 coronary artery STX16andNPEPL1.b 518 to 1100 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BX283599 eye, normal pigmented retinal epithelium STX16andNPEPL1.b 576 to 1082 1 to 507       507/507
(100 %)
1 diff
(99.9 %id)
CR735634 eye, normal pigmented retinal epithelium STX16andNPEPL1.b 576 to 1079 40 to 542       503/542
(92 %)
6 diff
(98.9 %id)
BG749194 eye, normal pigmented retinal epithelium STX16andNPEPL1.b 576 to 1523 1 to 942       942/979
(96 %)
24 diff
(97.6 %id)
BM700163 eye, lens STX16andNPEPL1.b 580 to 1110 1 to 531   fully sequenced, Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 531/531
(100 %)
0 diff
(100 %id)
AW962291   STX16andNPEPL1.b 638 to 1213 1 to 576       576/579
(99 %)
16 diff
(97.3 %id)
AI459549 brain, meningioma STX16andNPEPL1.b 653 to 1160 1 to 508     Submitted on the opposite strand 508/508
(100 %)
5 diff
(99.1 %id)
BQ299892 bladder_tumor STX16andNPEPL1.b 656 to 1165 526 to 22       503/526
(95 %)
1 diff
(99.9 %id)
BQ376735 uterus STX16andNPEPL1.b 668 to 1123 13 to 462       450/472
(95 %)
31 diff
(93.5 %id)
BQ712421 Spleen STX16andNPEPL1.b 686 to 1451 1 to 766       766/929
(82 %)
3 diff
(99.7 %id)
CU456762 epidermis STX16andNPEPL1.b 699 to 1060 376 to 14     Submitted on the opposite strand 363/383
(94 %)
4 diff
(99.0 %id)
BG419338 Kidney, renal cell adenocarcinoma STX16andNPEPL1.b 803 to 1540 1 to 728       728/940
(77 %)
19 diff
(98.0 %id)
BM670170 eye, lens STX16andNPEPL1.b 1080 to 1701 640 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 622/622
(100 %)
3 diff
(99.6 %id)
AA455567 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus STX16andNPEPL1.b 1081 to 1371 1 to 289   fully sequenced,   289/289
(100 %)
7 diff
(97.6 %id)
AA398062   STX16andNPEPL1.b 1138 to 1694 583 to 27   AAA Submitted on the opposite strand 557/558
(99 %)
19 diff
(96.6 %id)
CV372997 lung_normal STX16andNPEPL1.b 1158 to 1624 59 to 524       466/493
(94 %)
1 diff
(99.8 %id)
AW044341 pooled STX16andNPEPL1.b 1173 to 1713 564 to 24   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 541/541
(100 %)
19 diff
(96.5 %id)
BY799010 eye STX16andNPEPL1.b 1247 to 1815 1 to 569       569/569
(100 %)
3 diff
(99.5 %id)
AA456064 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus STX16andNPEPL1.b 1310 to 1695 385 to 1   fully sequenced,   385/385
(100 %)
5 diff
(98.8 %id)
BE833021 ovary STX16andNPEPL1.b 1336 to 1778 1 to 441   tiling clone,   441/441
(100 %)
5 diff
(98.9 %id)
BI011263 lung_normal STX16andNPEPL1.b 1394 to 1777 1 to 387       387/387
(100 %)
16 diff
(95.9 %id)
BI011330 lung_normal STX16andNPEPL1.b 1411 to 1784 383 to 10       374/383
(97 %)
1 diff
(99.8 %id)
BM904412 leiomyosarcoma, uterus STX16andNPEPL1.b 1425 to 1800 1 to 376       376/1237
(30 %)
2 diff
(99.9 %id)
AA291855 ovarian tumor, ovary STX16andNPEPL1.b 1601 to 1675 1 to 75   fully sequenced,   75/75
(100 %)
1 diff
(98.7 %id)
AA291733 ovarian tumor, ovary STX16andNPEPL1.b 1635 to 1695 61 to 1   fully sequenced,   61/61
(100 %)
0 diff
(100 %id)
AK297667 heart STX16andNPEPL1.c 1 to 1780 1 to 1780 L454P L465V tiling clone,   1780/1780
(100 %)
4 diff
(99.8 %id)
DC354322 heart STX16andNPEPL1.c 1 to 574 1 to 574       574/574
(100 %)
0 diff
(100 %id)
DB085754 testis STX16andNPEPL1.c 1652 to 2205 2 to 556   tiling clone, capped   555/555
(100 %)
3 diff
(99.5 %id)
BX396178 Placenta Cot 25-normalized STX16andNPEPL1.d 1 to 911 33 to 927   tiling clone,   895/935
(95 %)
24 diff
(97.5 %id)
AK124479 cerebellum STX16andNPEPL1.d 1262 to 3321 1 to 2060   tiling clone, available from FLJ,   2060/2060
(100 %)
4 diff
(99.9 %id)
CU446974 epidermis STX16andNPEPL1.d 1978 to 2533 574 to 19     Submitted on the opposite strand 556/574
(96 %)
0 diff
(100 %id)
BX373122 Placenta Cot 25-normalized STX16andNPEPL1.d 2090 to 2885 801 to 11       791/906
(87 %)
28 diff
(97.0 %id)
CV360421 head_normal STX16andNPEPL1.d 2135 to 2502 370 to 1     Submitted on the opposite strand 370/370
(100 %)
11 diff
(97.1 %id)
AA515452 liposarcoma STX16andNPEPL1.d 2274 to 2730 1 to 454       454/454
(100 %)
12 diff
(97.4 %id)
BI915059 brain STX16andNPEPL1.d 2280 to 3026 1 to 747       747/749
(99 %)
13 diff
(98.3 %id)
TI_57239071   STX16andNPEPL1.d 2280 to 3026 34 to 780       747/782
(95 %)
19 diff
(97.6 %id)
AI699125 carcinoid, lung STX16andNPEPL1.d 2297 to 2558 20 to 281     Submitted on the opposite strand 262/262
(100 %)
0 diff
(100 %id)
BM023434 Islets of Langerhans, Pancreas STX16andNPEPL1.e 1 to 279 279 to 1   tiling clone, AAA Submitted on the opposite strand 279/300
(93 %)
8 diff
(97.4 %id)
BX348232 Neuroblastoma Cot 25-normalized STX16andNPEPL1.e 11 to 502 497 to 1     Submitted on the opposite strand 497/501
(99 %)
6 diff
(98.9 %id)
BP397767 pancreatic islet STX16andNPEPL1.e 29 to 525 499 to 1       499/499
(100 %)
2 diff
(99.6 %id)
CR617956 neuroblastoma STX16andNPEPL1.e 30 to 1187 1158 to 1   tiling clone, Submitted on the opposite strand 1158/1158
(100 %)
0 diff
(100 %id)
BX433772 neuroblastoma STX16andNPEPL1.e 46 to 606 22 to 585     Submitted on the opposite strand 564/912
(61 %)
16 diff
(98.3 %id)
AA364486 pineal body STX16andNPEPL1.e 193 to 419 226 to 1     Submitted on the opposite strand 226/226
(100 %)
1 diff
(99.6 %id)
BX404072 neuroblastoma STX16andNPEPL1.e 313 to 1169 871 to 16     Submitted on the opposite strand 856/871
(98 %)
0 diff
(100 %id)
DB473820 hippocampus STX16andNPEPL1.e 515 to 1002 1 to 488       488/488
(100 %)
13 diff
(97.4 %id)
DB475528 hippocampus STX16andNPEPL1.e 515 to 990 1 to 476       476/476
(100 %)
1 diff
(99.8 %id)
CN417682 embryonic stem cells, cell lines H1, H7, andH9 STX16andNPEPL1.e 530 to 1068 13 to 552       540/552
(97 %)
6 diff
(99.0 %id)
CN417679 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells STX16andNPEPL1.e 540 to 1175 1 to 637       637/637
(100 %)
3 diff
(99.6 %id)
AB209296 brain STX16andNPEPL1.e 714 to 4146 1 to 3433 exact tiling clone,   3433/3433
(100 %)
6 diff
(99.9 %id)
AL135177 melanoma (MeWo cell line) STX16andNPEPL1.e 1147 to 1341 1 to 192       192/192
(100 %)
3 diff
(98.5 %id)
CN417684 embryonic stem cells, DMSO-treated H9 cellline STX16andNPEPL1.e 1314 to 1845 1 to 532       532/532
(100 %)
3 diff
(99.5 %id)
AL120975 melanoma (MeWo cell line) STX16andNPEPL1.e 1448 to 1874 1 to 427       427/427
(100 %)
1 diff
(99.8 %id)
DA768098 brain STX16andNPEPL1.e 1454 to 2030 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA888418   STX16andNPEPL1.e 1454 to 2028 2 to 576   tiling clone, capped   575/576
(99 %)
1 diff
(99.9 %id)
DB148958 thymus STX16andNPEPL1.e 1540 to 2105 2 to 568   capped   567/567
(100 %)
3 diff
(99.5 %id)
BI114016 muscle, rhabdomyosarcoma STX16andNPEPL1.e 1637 to 2158 1 to 530       528/799
(66 %)
20 diff
(97.5 %id)
AW849311 colon STX16andNPEPL1.e 1709 to 1811 1 to 103       103/103
(100 %)
0 diff
(100 %id)
AV746848 Pituitary STX16andNPEPL1.e 1844 to 2168 1 to 318       318/365
(87 %)
12 diff
(96.8 %id)
BF922411 nervous_tumor STX16andNPEPL1.e 1859 to 1959 100 to 1     Submitted on the opposite strand 100/113
(88 %)
3 diff
(97.4 %id)
AW382368 head_neck STX16andNPEPL1.e 2020 to 2137 1 to 119       119/119
(100 %)
2 diff
(98.4 %id)
BE147200 head_neck STX16andNPEPL1.e 2026 to 2137 1 to 112       112/112
(100 %)
0 diff
(100 %id)
DA373531 thalamus STX16andNPEPL1.e 2559 to 3105 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
BG331514 large cell carcinoma, lung STX16andNPEPL1.e 2562 to 3094 1 to 541       538/1092
(49 %)
20 diff
(98.2 %id)
AL732299 breast STX16andNPEPL1.e 2594 to 3015 433 to 11       424/440
(96 %)
0 diff
(100 %id)
AL731956 breast STX16andNPEPL1.e 2615 to 3015 1 to 399   tiling clone,   399/401
(99 %)
3 diff
(99.3 %id)
DA537308 Kidney STX16andNPEPL1.e 2660 to 3162 2 to 504   capped   503/503
(100 %)
0 diff
(100 %id)
CD632196   STX16andNPEPL1.e 2672 to 2871 199 to 1       199/199
(100 %)
1 diff
(99.5 %id)
CD632195   STX16andNPEPL1.e 2674 to 2871 1 to 199       199/200
(99 %)
4 diff
(98.0 %id)
T09094   STX16andNPEPL1.e 2743 to 3069 1 to 328       328/329
(99 %)
4 diff
(98.8 %id)
CN259744 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 STX16andNPEPL1.e 2754 to 3454 18 to 714       697/714
(97 %)
7 diff
(99.1 %id)
BQ322785 colon_est STX16andNPEPL1.e 2875 to 3214 380 to 41       340/387
(87 %)
9 diff
(97.7 %id)
CK905390 insulinoma, Pancreas STX16andNPEPL1.e 3021 to 3626 1 to 606     Submitted on the opposite strand 606/606
(100 %)
1 diff
(99.9 %id)
BU070643 insulinoma, Pancreas STX16andNPEPL1.e 3023 to 3549 1 to 527     Submitted on the opposite strand 527/527
(100 %)
1 diff
(99.9 %id)
CX869239 embryonic stem STX16andNPEPL1.e 3245 to 4009 1 to 765   fully sequenced,   765/765
(100 %)
1 diff
(99.9 %id)
AL449621 testis STX16andNPEPL1.e 3316 to 3680 368 to 4       365/415
(87 %)
13 diff
(96.9 %id)
AL731978 breast STX16andNPEPL1.e 3327 to 3720 395 to 1       395/395
(100 %)
8 diff
(98.0 %id)
AL731977 breast STX16andNPEPL1.e 3328 to 3790 1 to 463       463/466
(99 %)
6 diff
(98.8 %id)
BP316163 pericardium STX16andNPEPL1.e 3332 to 3913 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BM744594 stomach STX16andNPEPL1.e 3401 to 3661 1 to 262       262/262
(100 %)
9 diff
(96.6 %id)
BG026214 Bone, osteosarcoma, cell line STX16andNPEPL1.e 3422 to 4130 1 to 716   AAA   716/733
(97 %)
20 diff
(97.3 %id)
CA306973 Alveolar Macrophage, lung STX16andNPEPL1.e 3422 to 4146 743 to 19   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 725/725
(100 %)
2 diff
(99.8 %id)
BM689055 eye, eye anterior segment STX16andNPEPL1.e 3461 to 3772 9 to 320   fully sequenced, Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 312/320
(97 %)
2 diff
(99.4 %id)
CV352424 head_normal STX16andNPEPL1.e 3492 to 3908 459 to 37     Submitted on the opposite strand 423/460
(91 %)
12 diff
(97.4 %id)
AW884291 ovary STX16andNPEPL1.e 3557 to 3869 1 to 311       311/315
(98 %)
11 diff
(96.6 %id)
BF108431 carcinoid, lung STX16andNPEPL1.e 3612 to 3993 1 to 382     Submitted on the opposite strand 382/382
(100 %)
8 diff
(98.0 %id)
BF361999 nervous_normal STX16andNPEPL1.e 3620 to 3838 23 to 244       222/244
(90 %)
6 diff
(97.6 %id)
BU727249 eye, eye anterior segment STX16andNPEPL1.e 3742 to 4146 423 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 405/405
(100 %)
1 diff
(99.8 %id)
AA310438   STX16andNPEPL1.e 3844 to 4109 266 to 1     Submitted on the opposite strand 266/266
(100 %)
3 diff
(98.9 %id)
BF855032 prostate_normal STX16andNPEPL1.e 3887 to 4066 17 to 195       179/195
(91 %)
6 diff
(97.0 %id)
CX869160 embryonic stem STX16andNPEPL1.e 3984 to 4579 624 to 29   tiling clone, fully sequenced, AAA   596/596
(100 %)
6 diff
(99.0 %id)
BX396221 Placenta Cot 25-normalized STX16andNPEPL1.f 1 to 973 1 to 984   tiling clone, fully sequenced,   984/984
(100 %)
8 diff
(99.2 %id)
NM_001001433.1   STX16andNPEPL1.g 1 to 4946 1 to 4946 exact RefSeq, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 4946/4946
(100 %)
1 diff
(100.0 %id)
AF008936 brain STX16andNPEPL1.g 595 to 1750 1 to 1152 L99S A142P L143C P144R S145A ... tiling clone,   1152/1152
(100 %)
7 diff
(99.4 %id)
AK026970   STX16andNPEPL1.g 851 to 4061 1 to 3211   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 3211/3211
(100 %)
9 diff
(99.8 %id)
NM_001134772.1   STX16andNPEPL1.h 1 to 4936 1 to 4936 exact RefSeq,   4936/4936
(100 %)
1 diff
(100.0 %id)
BU844980 ovary, teratocarcinoma, cell line STX16andNPEPL1.h 36 to 866 1 to 833   tiling clone,   833/884
(94 %)
3 diff
(99.7 %id)
AW606511 head_neck STX16andNPEPL1.h 608 to 1172 582 to 19       564/582
(96 %)
1 diff
(99.9 %id)
BC073876 Bone, osteosarcoma STX16andNPEPL1.h 671 to 3118 1 to 2448 exact tiling clone, available from MGC, AAA   2448/2448
(100 %)
0 diff
(100 %id)
BG112896 Bone, osteosarcoma, cell line STX16andNPEPL1.h 672 to 1185 1 to 514       514/514
(100 %)
0 diff
(100 %id)
BG113954 Bone, osteosarcoma, cell line STX16andNPEPL1.h 672 to 1326 1 to 655       655/655
(100 %)
0 diff
(100 %id)
EL736947 mixed STX16andNPEPL1.h 736 to 1358 1 to 623       623/623
(100 %)
0 diff
(100 %id)
NM_001134773.1   STX16andNPEPL1.i 1 to 4897 1 to 4897 exact RefSeq,   4897/4897
(100 %)
1 diff
(100.0 %id)
BF871535 lung_tumor STX16andNPEPL1.i 11 to 317 1 to 307   tiling clone,   307/307
(100 %)
0 diff
(100 %id)
BU180474 epidermoid carcinoma, cell line, salivary gland STX16andNPEPL1.i 19 to 805 1 to 793       793/922
(86 %)
24 diff
(97.4 %id)
BQ669311 epidermoid carcinoma, cell line, salivary gland STX16andNPEPL1.i 19 to 810 1 to 798       798/976
(81 %)
33 diff
(96.7 %id)
BU844780 ovary, teratocarcinoma, cell line STX16andNPEPL1.i 36 to 798 1 to 780       780/792
(98 %)
25 diff
(96.9 %id)
DN989810 brain, whole brain STX16andNPEPL1.i 248 to 868 1 to 621   tiling clone,   621/621
(100 %)
4 diff
(99.4 %id)
CN417675 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells STX16andNPEPL1.i 321 to 952 1 to 632       632/632
(100 %)
0 diff
(100 %id)
DN998843 bone marrow STX16andNPEPL1.i 443 to 1159 1 to 717       717/717
(100 %)
5 diff
(99.4 %id)
CN417672 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells STX16andNPEPL1.i 681 to 1334 1 to 654   tiling clone,   654/654
(100 %)
3 diff
(99.6 %id)
AF038897   STX16andNPEPL1.i 736 to 1662 1 to 924 A125P L126C P127R S128A R129G ...     924/924
(100 %)
7 diff
(99.3 %id)
DA237562 brain STX16andNPEPL1.i 771 to 1358 2 to 590   capped   589/589
(100 %)
2 diff
(99.7 %id)
BU844520 ovary, teratocarcinoma, cell line STX16andNPEPL1.i 784 to 1677 1 to 898       898/901
(99 %)
8 diff
(99.2 %id)
CK000613 mixed STX16andNPEPL1.i 958 to 1724 1 to 765       765/765
(100 %)
8 diff
(99.0 %id)
CN417671 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 STX16andNPEPL1.i 1109 to 1694 1 to 586   tiling clone,   586/586
(100 %)
0 diff
(100 %id)
DA028237   STX16andNPEPL1.i 1199 to 1769 2 to 574   capped   573/573
(100 %)
3 diff
(99.5 %id)
BE781705 eye, retinoblastoma STX16andNPEPL1.i 1241 to 1920 2 to 683       682/750
(90 %)
6 diff
(99.2 %id)
BE881751 large cell carcinoma, undifferentiated, lung STX16andNPEPL1.i 1249 to 1852 1 to 604       604/1077
(56 %)
6 diff
(99.5 %id)
DA499657 brain STX16andNPEPL1.i 1258 to 1806 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA218906 brain STX16andNPEPL1.i 1274 to 1931 2 to 659   capped   658/658
(100 %)
0 diff
(100 %id)
DB143779 thymus STX16andNPEPL1.i 1274 to 1829 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BP376147 uterus STX16andNPEPL1.i 1292 to 1841 1 to 550       550/550
(100 %)
1 diff
(99.9 %id)
AA100145 colon, tumor STX16andNPEPL1.i 1415 to 1802 1 to 390       390/390
(100 %)
2 diff
(99.5 %id)
DA547248   STX16andNPEPL1.i 1416 to 1975 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
CK000445 mixed STX16andNPEPL1.i 1429 to 2228 1 to 792       792/809
(97 %)
19 diff
(97.7 %id)
DB173243 kidney, tumor tissue STX16andNPEPL1.i 1469 to 1837 2 to 370   capped   369/369
(100 %)
0 diff
(100 %id)
AL118944 amygdala STX16andNPEPL1.i 1470 to 2024 1 to 555       555/555
(100 %)
1 diff
(99.9 %id)
BU845858 ovary, teratocarcinoma, cell line STX16andNPEPL1.i 1503 to 2273 1 to 776       776/916
(84 %)
8 diff
(99.2 %id)
DA444984 tongue, tumor tissue STX16andNPEPL1.i 1507 to 2087 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DA145662 amygdala STX16andNPEPL1.i 1509 to 2072 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
BE937267 stomach STX16andNPEPL1.i 1550 to 1893 1 to 344       344/344
(100 %)
0 diff
(100 %id)
CR989895 T-Lymphocytes STX16andNPEPL1.i 1564 to 2306 1 to 745       745/745
(100 %)
4 diff
(99.5 %id)
DA260169 caudate nucleus STX16andNPEPL1.i 1576 to 2156 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA018084 adrenal gland STX16andNPEPL1.i 1581 to 2147 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA161686 amygdala STX16andNPEPL1.i 1582 to 2145 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
BM471414 melanotic melanoma, skin STX16andNPEPL1.i 1598 to 2447 25 to 880   tiling clone,   856/1007
(85 %)
21 diff
(98.0 %id)
DA506214 brain STX16andNPEPL1.i 1606 to 2169 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DB249251 uterus STX16andNPEPL1.i 1606 to 2167 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
BE843000 stomach STX16andNPEPL1.i 1669 to 1853 191 to 8       184/191
(96 %)
0 diff
(100 %id)
BF156017 stomach STX16andNPEPL1.i 1669 to 1827 171 to 9       163/171
(95 %)
0 diff
(100 %id)
BF830113 head_normal STX16andNPEPL1.i 1697 to 1883 185 to 3     Submitted on the opposite strand 183/214
(85 %)
0 diff
(100 %id)
AL359056   STX16andNPEPL1.i 1762 to 1908 158 to 12     Submitted on the opposite strand 147/158
(93 %)
0 diff
(100 %id)
BM894060 insulinoma, Pancreas STX16andNPEPL1.i 1766 to 2364 1 to 599     Submitted on the opposite strand 599/599
(100 %)
0 diff
(100 %id)
AA311035   STX16andNPEPL1.i 1785 to 2261 1 to 476       476/476
(100 %)
3 diff
(99.4 %id)
AW958296   STX16andNPEPL1.i 1786 to 2478 1 to 694       694/694
(100 %)
6 diff
(99.2 %id)
W42622 Pancreas, pancreatic islet STX16andNPEPL1.i 1787 to 1900 1 to 114     Submitted on the opposite strand 114/114
(100 %)
0 diff
(100 %id)
W42618 Pancreas, pancreatic islet STX16andNPEPL1.i 1787 to 1901 1 to 115     Submitted on the opposite strand 115/115
(100 %)
0 diff
(100 %id)
AA167528   STX16andNPEPL1.i 1787 to 2185 1 to 399     Submitted on the opposite strand 399/399
(100 %)
0 diff
(100 %id)
AA489328   STX16andNPEPL1.i 1787 to 2283 1 to 497     Submitted on the opposite strand 497/498
(99 %)
2 diff
(99.6 %id)
W40536 Pancreas, pancreatic islet STX16andNPEPL1.i 1789 to 1908 131 to 12     Submitted on the opposite strand 120/131
(91 %)
0 diff
(100 %id)
W40487 Pancreas, pancreatic islet STX16andNPEPL1.i 1790 to 1908 130 to 12     Submitted on the opposite strand 119/130
(91 %)
0 diff
(100 %id)
W40488 Pancreas, pancreatic islet STX16andNPEPL1.i 1790 to 1908 130 to 12     Submitted on the opposite strand 119/130
(91 %)
0 diff
(100 %id)
W40537 Pancreas, pancreatic islet STX16andNPEPL1.i 1791 to 1908 129 to 12     Submitted on the opposite strand 118/129
(91 %)
0 diff
(100 %id)
W42617 Pancreas, pancreatic islet STX16andNPEPL1.i 1804 to 1900 1 to 97     Submitted on the opposite strand 97/97
(100 %)
0 diff
(100 %id)
CK824087 insulinoma, Pancreas STX16andNPEPL1.i 1822 to 2355 1 to 534     Submitted on the opposite strand 534/534
(100 %)
0 diff
(100 %id)
DB172423 kidney, tumor tissue STX16andNPEPL1.i 1828 to 2410 2 to 586   capped   585/585
(100 %)
2 diff
(99.7 %id)
BX950933   STX16andNPEPL1.i 1841 to 2415 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
DB142807 thymus STX16andNPEPL1.i 1851 to 2389 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DA346591 substantia nigra STX16andNPEPL1.i 1864 to 2405 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DB155801 thymus STX16andNPEPL1.i 1867 to 2446 2 to 584   capped   583/583
(100 %)
2 diff
(99.7 %id)
AV728943 hypothalamus STX16andNPEPL1.i 1872 to 2313 1 to 442       442/442
(100 %)
0 diff
(100 %id)
BI256634 cervical carcinoma cell line, cervix STX16andNPEPL1.i 1883 to 2586 1 to 702       702/702
(100 %)
4 diff
(99.5 %id)
AK026974   STX16andNPEPL1.i 1884 to 4010 1 to 2125   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2125/2126
(99 %)
8 diff
(99.7 %id)
BX953017   STX16andNPEPL1.i 1900 to 2392 1 to 493       493/493
(100 %)
4 diff
(99.2 %id)
AV721905 hypothalamus STX16andNPEPL1.i 1933 to 2605 1 to 666       666/677
(98 %)
6 diff
(99.2 %id)
DA015120 adrenal gland STX16andNPEPL1.i 1939 to 2510 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB108772 thymus STX16andNPEPL1.i 1973 to 2560 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
BE878126 large cell carcinoma, undifferentiated, lung STX16andNPEPL1.i 1983 to 2691 1 to 703       703/939
(74 %)
20 diff
(97.9 %id)
CN348571 embryonic stem cells, cell lines H1, H7, andH9 STX16andNPEPL1.i 1995 to 2690 1 to 695       695/695
(100 %)
1 diff
(99.9 %id)
DA378549 thalamus STX16andNPEPL1.i 1996 to 2567 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB193912 ovary, tumor tissue STX16andNPEPL1.i 2007 to 2573 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
AU253699 neuroblastoma STX16andNPEPL1.i 2041 to 2683 53 to 696       644/697
(92 %)
6 diff
(99.2 %id)
DA938545 Spleen STX16andNPEPL1.i 2042 to 2635 2 to 597   capped   596/596
(100 %)
2 diff
(99.7 %id)
DA074923 cerebellum STX16andNPEPL1.i 2048 to 2633 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
AL602274 human skeletal muscle STX16andNPEPL1.i 2059 to 2584 1 to 526       526/528
(99 %)
1 diff
(99.9 %id)
BX102625 placenta STX16andNPEPL1.i 2075 to 2800 1 to 726       726/726
(100 %)
1 diff
(99.9 %id)
DA870536 Prostate STX16andNPEPL1.i 2095 to 2636 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
BF900847 marrow STX16andNPEPL1.i 2138 to 2495 358 to 1     Submitted on the opposite strand 358/358
(100 %)
4 diff
(98.9 %id)
DA376717 thalamus STX16andNPEPL1.i 2175 to 2726 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
Z41983 brain, total brain STX16andNPEPL1.i 2187 to 2396 1 to 210       210/210
(100 %)
0 diff
(100 %id)
BE168567 head_neck STX16andNPEPL1.i 2188 to 2556 370 to 1     Submitted on the opposite strand 370/370
(100 %)
5 diff
(98.7 %id)
DA377272 thalamus STX16andNPEPL1.i 2193 to 2759 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA061954 cerebellum STX16andNPEPL1.i 2198 to 2762 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA426199 colon STX16andNPEPL1.i 2240 to 2796 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
BQ220461 melanotic melanoma, skin STX16andNPEPL1.i 2252 to 3021 1 to 779       779/863
(90 %)
14 diff
(98.4 %id)
BU189467 melanotic melanoma, skin STX16andNPEPL1.i 2261 to 3010 12 to 774       763/856
(89 %)
18 diff
(97.9 %id)
DA062024 cerebellum STX16andNPEPL1.i 2264 to 2826 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA831636 placenta STX16andNPEPL1.i 2266 to 3013 2 to 751   capped   750/755
(99 %)
4 diff
(99.5 %id)
DB039065 testis STX16andNPEPL1.i 2268 to 2822 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA933658 Spleen STX16andNPEPL1.i 2279 to 2838 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
CN348569 embryonic stem cells, cell lines H1, H7, andH9 STX16andNPEPL1.i 2283 to 2947 1 to 665       665/665
(100 %)
5 diff
(99.3 %id)
CX751413 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass STX16andNPEPL1.i 2291 to 3022 40 to 767     Submitted on the opposite strand 728/863
(84 %)
5 diff
(99.5 %id)
AL047428 uterus STX16andNPEPL1.i 2294 to 2794 1 to 501       501/501
(100 %)
0 diff
(100 %id)
BG699315 brain, hippocampus STX16andNPEPL1.i 2298 to 2892 1 to 595       595/595
(100 %)
4 diff
(99.4 %id)
DB483636 hippocampus STX16andNPEPL1.i 2305 to 2759 1 to 455       455/455
(100 %)
0 diff
(100 %id)
BQ233112 melanotic melanoma, skin STX16andNPEPL1.i 2332 to 3080 1 to 758       758/969
(78 %)
14 diff
(98.6 %id)
BF204725 muscle, rhabdomyosarcoma STX16andNPEPL1.i 2335 to 2893 1 to 559       559/559
(100 %)
1 diff
(99.9 %id)
CN348570 embryonic stem cells, cell lines H1, H7, andH9 STX16andNPEPL1.i 2341 to 2772 1 to 432       432/432
(100 %)
0 diff
(100 %id)
BE178290 head_neck STX16andNPEPL1.i 2352 to 2991 646 to 10     Submitted on the opposite strand 637/649
(98 %)
0 diff
(100 %id)
BQ015099 Chondrosarcoma, Left Pubic Bone STX16andNPEPL1.i 2369 to 3090 735 to 17   AAA   719/730
(98 %)
2 diff
(99.8 %id)
DA022101   STX16andNPEPL1.i 2373 to 2928 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BF773450 epid_tumor STX16andNPEPL1.i 2388 to 2730 399 to 45     Submitted on the opposite strand 355/405
(87 %)
0 diff
(100 %id)
CO245541 Chondrosarcoma Lung Metastasis cell lines, lung STX16andNPEPL1.i 2412 to 3121 8 to 708       701/815
(86 %)
10 diff
(98.8 %id)
CX165893 human embryonic stem cells differentiated toan early endodermal cell type STX16andNPEPL1.i 2457 to 3211 1 to 755       755/755
(100 %)
0 diff
(100 %id)
BI062387 uterus_tumor STX16andNPEPL1.i 2497 to 2774 278 to 1       278/278
(100 %)
1 diff
(99.7 %id)
BI062464 uterus_tumor STX16andNPEPL1.i 2497 to 2774 278 to 1       278/278
(100 %)
2 diff
(99.3 %id)
BI062557 uterus_tumor STX16andNPEPL1.i 2497 to 2774 278 to 1       278/278
(100 %)
7 diff
(97.5 %id)
CN348573 embryonic stem cells, DMSO-treated H9 cellline STX16andNPEPL1.i 2506 to 3125 1 to 620       620/620
(100 %)
0 diff
(100 %id)
DA817066   STX16andNPEPL1.i 2548 to 3120 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DQ268529 brain STX16andNPEPL1.i 2550 to 3040 1 to 487       487/608
(80 %)
9 diff
(98.6 %id)
AA319231 adrenal gland STX16andNPEPL1.i 2565 to 2802 1 to 238       238/238
(100 %)
0 diff
(100 %id)
BF725677 eye, Iris STX16andNPEPL1.i 2582 to 3112 1 to 531       531/531
(100 %)
0 diff
(100 %id)
CN348568 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells STX16andNPEPL1.i 2582 to 3118 1 to 537       537/537
(100 %)
1 diff
(99.9 %id)
CK429624 eye, lacrimal gland STX16andNPEPL1.i 2582 to 3197 1 to 618       618/618
(100 %)
2 diff
(99.7 %id)
CN348575 embryonic stem cells, cell lines H1, H7, andH9 STX16andNPEPL1.i 2584 to 3286 12 to 714       703/714
(98 %)
6 diff
(99.2 %id)
DB170602 kidney, tumor tissue STX16andNPEPL1.i 2593 to 3169 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
AI016616   STX16andNPEPL1.i 2615 to 3057 446 to 4       443/446
(99 %)
0 diff
(100 %id)
L44457   STX16andNPEPL1.i 2648 to 3043 1 to 396       396/396
(100 %)
3 diff
(99.3 %id)
AA682368 liver and spleen STX16andNPEPL1.i 2656 to 3085 445 to 16   AAA   430/430
(100 %)
0 diff
(100 %id)
DB003643 breast, tumor tissue STX16andNPEPL1.i 2679 to 3234 2 to 561   capped   560/560
(100 %)
4 diff
(99.3 %id)
H63165 liver and spleen STX16andNPEPL1.i 2754 to 3087 335 to 1     Submitted on the opposite strand 335/341
(98 %)
1 diff
(99.8 %id)
BQ278963 adenocarcinoma, cell line, breast STX16andNPEPL1.i 2754 to 3398 1 to 651       651/950
(68 %)
19 diff
(98.0 %id)
EB387681 eye, optic nerve STX16andNPEPL1.i 2789 to 3587 1 to 799       799/799
(100 %)
4 diff
(99.5 %id)
BG273079 normal squamous epithelium from retromolartrigone STX16andNPEPL1.i 2813 to 3160 1 to 348       348/348
(100 %)
0 diff
(100 %id)
BG762667 melanotic melanoma, high MDR (cell line), skin STX16andNPEPL1.i 2837 to 3646 1 to 812       812/813
(99 %)
13 diff
(98.5 %id)
DA614136   STX16andNPEPL1.i 2862 to 3432 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
BU933840 mixed (pool of 40 RNAs) STX16andNPEPL1.i 2866 to 3665 1 to 809       809/810
(99 %)
32 diff
(96.1 %id)
DA265400 caudate nucleus STX16andNPEPL1.i 2869 to 3344 2 to 477   capped   476/476
(100 %)
0 diff
(100 %id)
DB468956 hippocampus STX16andNPEPL1.i 2880 to 3304 1 to 425       425/425
(100 %)
1 diff
(99.8 %id)
DA556385   STX16andNPEPL1.i 2893 to 3466 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
BE836409 prostate_normal STX16andNPEPL1.i 2913 to 3418 519 to 14       506/519
(97 %)
0 diff
(100 %id)
BE836415 prostate_normal STX16andNPEPL1.i 2914 to 3418 516 to 12       505/516
(97 %)
0 diff
(100 %id)
BE836412 prostate_normal STX16andNPEPL1.i 2929 to 3418 501 to 11       491/501
(98 %)
0 diff
(100 %id)
BM785856 Ascites, stomach STX16andNPEPL1.i 2937 to 3495 1 to 559       559/559
(100 %)
2 diff
(99.7 %id)
BF370443 prostate_normal STX16andNPEPL1.i 2940 to 3418 488 to 10       479/488
(98 %)
0 diff
(100 %id)
BE836408 prostate_normal STX16andNPEPL1.i 2942 to 3418 486 to 10       477/486
(98 %)
0 diff
(100 %id)
BF370444 prostate_normal STX16andNPEPL1.i 2949 to 3418 478 to 8       471/478
(98 %)
0 diff
(100 %id)
BF370434 prostate_normal STX16andNPEPL1.i 2981 to 3418 445 to 8       438/445
(98 %)
0 diff
(100 %id)
AF305817 Liver STX16andNPEPL1.i 3007 to 4778 6 to 1779   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1774/1779
(99 %)
8 diff
(99.6 %id)
AI064903 Liver STX16andNPEPL1.i 3007 to 3322 6 to 321       316/321
(98 %)
11 diff
(96.6 %id)
DA840405 placenta STX16andNPEPL1.i 3020 to 3568 2 to 551   capped   550/550
(100 %)
2 diff
(99.7 %id)
AI989398 thymus, pooled STX16andNPEPL1.i 3026 to 3468 1 to 443     Submitted on the opposite strand 443/443
(100 %)
4 diff
(99.1 %id)
BM998893 lung, Lung Focal Fibrosis STX16andNPEPL1.i 3078 to 3709 645 to 14   AAA   632/632
(100 %)
2 diff
(99.7 %id)
DB202652 trachea STX16andNPEPL1.i 3099 to 3577 2 to 480   capped   479/479
(100 %)
1 diff
(99.8 %id)
BU619602 Cell Line, Chondrosarcoma STX16andNPEPL1.i 3127 to 3852 740 to 17   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 724/724
(100 %)
4 diff
(99.5 %id)
TI_149296658   STX16andNPEPL1.i 3245 to 4010 845 to 82   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 764/922
(82 %)
14 diff
(98.5 %id)
TI_154137156   STX16andNPEPL1.i 3305 to 4010 790 to 89   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 702/900
(78 %)
32 diff
(96.5 %id)
CA427122 Bone, Subchondral Bone STX16andNPEPL1.i 3306 to 4028 722 to 1       722/722
(100 %)
2 diff
(99.8 %id)
BF527243 anaplastic oligodendroglioma with 1p/19qloss, brain STX16andNPEPL1.i 3310 to 4010 1 to 699   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 699/699
(100 %)
7 diff
(99.0 %id)
CA412947 Chondrosarcoma Grade II, Left Pelvis STX16andNPEPL1.i 3312 to 4028 717 to 1       717/717
(100 %)
6 diff
(99.2 %id)
BM969198 lung, Primary Lung Cystic Fibrosis EpithelialCells STX16andNPEPL1.i 3325 to 4028 704 to 1   tiling clone,   704/706
(99 %)
2 diff
(99.8 %id)
BI495294 cochlea, ear STX16andNPEPL1.i 3382 to 4027 646 to 1       646/646
(100 %)
2 diff
(99.7 %id)
DQ272217 brain STX16andNPEPL1.i 3392 to 4010 1 to 619   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 619/619
(100 %)
4 diff
(99.4 %id)
DB377385 placenta STX16andNPEPL1.i 3434 to 4010 571 to 1       571/575
(99 %)
13 diff
(97.8 %id)
BQ004009 placenta STX16andNPEPL1.i 3485 to 4027 543 to 1       543/543
(100 %)
3 diff
(99.5 %id)
CU443997 epidermis STX16andNPEPL1.i 3495 to 3884 403 to 14     Submitted on the opposite strand 390/427
(91 %)
0 diff
(100 %id)
CU450712 epidermis STX16andNPEPL1.i 3495 to 3884 405 to 16     Submitted on the opposite strand 390/429
(90 %)
0 diff
(100 %id)
CU454365 epidermis STX16andNPEPL1.i 3495 to 3884 405 to 16     Submitted on the opposite strand 390/429
(90 %)
0 diff
(100 %id)
AI829831 lymph node, lymphoma, follicular mixed small and largecell STX16andNPEPL1.i 3530 to 4022 493 to 1       493/493
(100 %)
1 diff
(99.8 %id)
AI911671 adenocarcinoma, Pancreas STX16andNPEPL1.i 3553 to 4016 464 to 1       464/464
(100 %)
3 diff
(99.4 %id)
AI278678 carcinoid, lung STX16andNPEPL1.i 3559 to 4012 454 to 1       454/454
(100 %)
2 diff
(99.6 %id)
AA629872 lung, lung carcinoma STX16andNPEPL1.i 3562 to 4028 469 to 1   tiling clone,   469/469
(100 %)
8 diff
(98.3 %id)
AI570829 adenocarcinoma, Pancreas STX16andNPEPL1.i 3582 to 4013 432 to 1       432/432
(100 %)
1 diff
(99.8 %id)
AI249473 lymph node, lymphoma, follicular mixed small and largecell STX16andNPEPL1.i 3604 to 4025 422 to 1       422/422
(100 %)
2 diff
(99.6 %id)
AA167527   STX16andNPEPL1.i 3605 to 4001 395 to 1     Submitted on the opposite strand 395/396
(99 %)
7 diff
(98.3 %id)
AI334818 serous papillary carcinoma, high grade, 2pooled tumors, uterus STX16andNPEPL1.i 3609 to 4012 404 to 1       404/404
(100 %)
1 diff
(99.8 %id)
AL047429 uterus STX16andNPEPL1.i 3626 to 4010 410 to 26   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 385/385
(100 %)
1 diff
(99.8 %id)
AI338386   STX16andNPEPL1.i 3627 to 4014 388 to 1       388/388
(100 %)
1 diff
(99.8 %id)
AA814622 brain, substantia nigra STX16andNPEPL1.i 3629 to 4016 386 to 1       386/386
(100 %)
2 diff
(99.5 %id)
CN397259 embryonic stem cells, DMSO-treated H9 cellline STX16andNPEPL1.i 3633 to 4221 1 to 589       589/589
(100 %)
3 diff
(99.5 %id)
AA354822   STX16andNPEPL1.i 3668 to 4010 344 to 1     Submitted on the opposite strand 344/344
(100 %)
4 diff
(98.9 %id)
DB484430 hypothalamus STX16andNPEPL1.i 3781 to 4215 1 to 438       438/438
(100 %)
3 diff
(99.4 %id)
F01503 brain, total brain STX16andNPEPL1.i 3798 to 4009 212 to 1       212/212
(100 %)
0 diff
(100 %id)
CN397261 embryonic stem cells, cell lines H1, H7, andH9 STX16andNPEPL1.i 3881 to 4400 1 to 522       522/522
(100 %)
5 diff
(99.1 %id)
BM700340 eye, lens STX16andNPEPL1.i 3908 to 4249 1 to 345   fully sequenced, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 345/345
(100 %)
1 diff
(99.8 %id)
CR982093 T-Lymphocytes STX16andNPEPL1.i 3916 to 4759 1 to 847       847/852
(99 %)
3 diff
(99.7 %id)
TI_149280237   STX16andNPEPL1.i 3941 to 4779 923 to 93   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 831/1124
(73 %)
16 diff
(98.6 %id)
CA450362 Human Lung Epithelial cells, lung STX16andNPEPL1.i 3973 to 4262 39 to 332     Submitted on the opposite strand 294/332
(88 %)
6 diff
(98.2 %id)
TI_154127040   STX16andNPEPL1.i 3977 to 4783 890 to 84   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 807/813
(99 %)
6 diff
(99.3 %id)
TI_159714634   STX16andNPEPL1.i 3978 to 4754 109 to 883     Submitted on the opposite strand 775/1072
(72 %)
15 diff
(98.7 %id)
TI_159715308   STX16andNPEPL1.i 3978 to 4867 118 to 1007   AAA Submitted on the opposite strand 890/1007
(88 %)
17 diff
(98.4 %id)
BF744833 breast STX16andNPEPL1.i 4025 to 4563 539 to 1     Submitted on the opposite strand 539/539
(100 %)
1 diff
(99.9 %id)
TI_154107242   STX16andNPEPL1.i 4036 to 4783 845 to 97   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 749/948
(79 %)
3 diff
(99.7 %id)
BF222575 Prostate STX16andNPEPL1.i 4037 to 4513 1 to 477     Submitted on the opposite strand 477/477
(100 %)
1 diff
(99.8 %id)
CA447005 Chondrosarcoma, Left Pubic Bone STX16andNPEPL1.i 4042 to 4783 760 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 742/744
(99 %)
3 diff
(99.6 %id)
CA416887 Chondrosarcoma Cell line STX16andNPEPL1.i 4046 to 4783 756 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 738/738
(100 %)
0 diff
(100 %id)
BE735967 adenocarcinoma, Pancreas STX16andNPEPL1.i 4052 to 4775 1 to 720       720/720
(100 %)
16 diff
(97.8 %id)
W28230 eye, retina STX16andNPEPL1.i 4115 to 4558 484 to 37       448/531
(84 %)
0 diff
(100 %id)
CB243022 Human Lung Epithelial cells, lung STX16andNPEPL1.i 4156 to 4870 728 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 713/713
(100 %)
2 diff
(99.8 %id)
CB240977 Human Lung Epithelial cells, lung STX16andNPEPL1.i 4172 to 4870 711 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 696/696
(100 %)
3 diff
(99.6 %id)
TI_154056312   STX16andNPEPL1.i 4191 to 4863 766 to 95   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 672/969
(69 %)
3 diff
(99.7 %id)
AW194704 Kidney STX16andNPEPL1.i 4201 to 4773 574 to 1       574/574
(100 %)
2 diff
(99.7 %id)
BM969896 lung, Primary Lung Epithelial Cells STX16andNPEPL1.i 4211 to 4779 586 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 568/568
(100 %)
1 diff
(99.9 %id)
CA418804 Chondrosarcoma Grade II, Left Pelvis STX16andNPEPL1.i 4211 to 4863 672 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 654/654
(100 %)
1 diff
(99.9 %id)
BU737996 eye, lens STX16andNPEPL1.i 4219 to 4783 583 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 565/565
(100 %)
0 diff
(100 %id)
AA256336 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus STX16andNPEPL1.i 4257 to 4594 1 to 336   fully sequenced, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 336/336
(100 %)
2 diff
(99.5 %id)
BM993587 lung, Metastatic Chondrosarcoma STX16andNPEPL1.i 4277 to 4867 605 to 15   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 591/591
(100 %)
0 diff
(100 %id)
DB544349 hippocampus STX16andNPEPL1.i 4288 to 4783 1 to 496     Submitted on the opposite strand 496/496
(100 %)
2 diff
(99.6 %id)
AI890882 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus STX16andNPEPL1.i 4296 to 4783 488 to 1       488/488
(100 %)
0 diff
(100 %id)
AW027820 poorly differentiated adenocarcinoma withsignet ring cell features, stomach STX16andNPEPL1.i 4302 to 4783 482 to 1       482/482
(100 %)
0 diff
(100 %id)
AI493393 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus STX16andNPEPL1.i 4335 to 4779 445 to 1       445/445
(100 %)
0 diff
(100 %id)
AW977869   STX16andNPEPL1.i 4341 to 4788 448 to 1     Submitted on the opposite strand 448/448
(100 %)
16 diff
(96.5 %id)
AW172483 pooled STX16andNPEPL1.i 4341 to 4773 433 to 1       433/433
(100 %)
0 diff
(100 %id)
AI288570 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus STX16andNPEPL1.i 4349 to 4785 437 to 1       437/437
(100 %)
0 diff
(100 %id)
BF057674 pooled germ cell tumors STX16andNPEPL1.i 4359 to 4867 509 to 1       509/509
(100 %)
0 diff
(100 %id)
BF593830 brain, glioblastoma (pooled) STX16andNPEPL1.i 4360 to 4863 504 to 1       504/504
(100 %)
0 diff
(100 %id)
BQ448500 Knee, Osteoarthritic Cartilage STX16andNPEPL1.i 4361 to 4783 440 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 422/422
(100 %)
2 diff
(99.6 %id)
AW874573 tumor, uterus STX16andNPEPL1.i 4362 to 4867 516 to 11   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 506/506
(100 %)
0 diff
(100 %id)
AI334393 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus STX16andNPEPL1.i 4363 to 4869 507 to 2       506/507
(99 %)
0 diff
(100 %id)
BE856414 brain, glioblastoma (pooled) STX16andNPEPL1.i 4375 to 4863 489 to 1       489/489
(100 %)
0 diff
(100 %id)
AA906113 pooled STX16andNPEPL1.i 4381 to 4787 408 to 2       407/408
(99 %)
0 diff
(100 %id)
BF594266 brain, glioblastoma (pooled) STX16andNPEPL1.i 4383 to 4863 481 to 1       481/481
(100 %)
2 diff
(99.6 %id)
BQ015638 placenta STX16andNPEPL1.i 4389 to 4867 492 to 14   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 479/479
(100 %)
0 diff
(100 %id)
DB552576 hippocampus STX16andNPEPL1.i 4391 to 4867 1 to 477     Submitted on the opposite strand 477/477
(100 %)
0 diff
(100 %id)
CN397260 embryonic stem cells, DMSO-treated H9 cellline STX16andNPEPL1.i 4400 to 4837 439 to 1     Submitted on the opposite strand 439/439
(100 %)
2 diff
(99.6 %id)
DB541185 hippocampus STX16andNPEPL1.i 4404 to 4867 1 to 464     Submitted on the opposite strand 464/464
(100 %)
2 diff
(99.6 %id)
AI356379 B-cell, chronic lymphotic leukemia STX16andNPEPL1.i 4404 to 4870 467 to 1       467/467
(100 %)
0 diff
(100 %id)
AI632175 pooled germ cell tumors STX16andNPEPL1.i 4404 to 4869 468 to 2       467/468
(99 %)
0 diff
(100 %id)
AI651286 pooled germ cell tumors STX16andNPEPL1.i 4404 to 4867 464 to 1       464/464
(100 %)
1 diff
(99.8 %id)
AI823467 Kidney STX16andNPEPL1.i 4404 to 4865 462 to 1       462/462
(100 %)
0 diff
(100 %id)
AA594117 colon, colon tumor RER+ STX16andNPEPL1.i 4415 to 4867 465 to 13   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 453/453
(100 %)
1 diff
(99.8 %id)
AI276677 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus STX16andNPEPL1.i 4416 to 4867 452 to 1       452/452
(100 %)
0 diff
(100 %id)
BE501312 pooled germ cell tumors STX16andNPEPL1.i 4421 to 4867 447 to 1       447/447
(100 %)
1 diff
(99.8 %id)
AI356428 B-cell, chronic lymphotic leukemia STX16andNPEPL1.i 4425 to 4871 448 to 2       447/448
(99 %)
0 diff
(100 %id)
AI027633   STX16andNPEPL1.i 4442 to 4869 429 to 2       428/429
(99 %)
0 diff
(100 %id)
AW076062 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood STX16andNPEPL1.i 4474 to 4867 404 to 11   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 394/394
(100 %)
1 diff
(99.8 %id)
AA831078 germinal center B cell STX16andNPEPL1.i 4482 to 4867 406 to 21   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 386/386
(100 %)
0 diff
(100 %id)
AA988565 carcinoid, lung STX16andNPEPL1.i 4500 to 4779 305 to 26   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 280/280
(100 %)
0 diff
(100 %id)
AA524825 ovary STX16andNPEPL1.i 4525 to 4867 1 to 343   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 343/343
(100 %)
0 diff
(100 %id)
AI457303 carcinoid, lung STX16andNPEPL1.i 4534 to 4751 1 to 218     Submitted on the opposite strand 218/218
(100 %)
0 diff
(100 %id)
AI871762 carcinoid, lung STX16andNPEPL1.i 4534 to 4751 1 to 218     Submitted on the opposite strand 218/218
(100 %)
0 diff
(100 %id)
BG149517 carcinoid, lung STX16andNPEPL1.i 4534 to 4750 1 to 217     Submitted on the opposite strand 217/217
(100 %)
0 diff
(100 %id)
AI040458 liver and spleen STX16andNPEPL1.i 4557 to 4863 307 to 1       307/307
(100 %)
0 diff
(100 %id)
AA256337 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus STX16andNPEPL1.i 4564 to 4894 342 to 15   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 328/328
(100 %)
3 diff
(99.1 %id)
CF137046 lymph STX16andNPEPL1.i 4711 to 4868 200 to 43   AAA Submitted on the opposite strand 158/162
(97 %)
0 diff
(100 %id)
AA170812   STX16andNPEPL1.i 4781 to 4869 93 to 5       89/96
(92 %)
0 diff
(100 %id)
NM_003763.4   STX16andNPEPL1.j 1 to 4885 1 to 4885 exact RefSeq,   4885/4885
(100 %)
1 diff
(100.0 %id)
BQ641592 eye, normal pigmented retinal epithelium STX16andNPEPL1.j 334 to 1229 1 to 905   tiling clone,   905/909
(99 %)
22 diff
(97.6 %id)
BC019042 Kidney, renal cell adenocarcinoma STX16andNPEPL1.j 527 to 3044 1 to 2518 exact tiling clone, available from MGC, AAA   2518/2518
(100 %)
0 diff
(100 %id)
CN417674 embryonic stem cells, cell lines H1, H7, andH9 STX16andNPEPL1.j 531 to 1144 1 to 614       614/614
(100 %)
2 diff
(99.7 %id)
AF008935   STX16andNPEPL1.j 595 to 1687 1 to 1089 L78S A121P L122C P123R S124A ...     1089/1089
(100 %)
7 diff
(99.4 %id)
BU429949 lymph STX16andNPEPL1.j 622 to 1048 1 to 426       426/426
(100 %)
8 diff
(98.2 %id)
TI_154151343   STX16andNPEPL1.j 630 to 1099 80 to 550       471/671
(70 %)
12 diff
(98.3 %id)
BE161763 head_neck STX16andNPEPL1.j 675 to 863 237 to 50     Submitted on the opposite strand 188/237
(79 %)
0 diff
(100 %id)
BQ881717 Spleen STX16andNPEPL1.j 736 to 1600 10 to 876       867/909
(95 %)
13 diff
(98.6 %id)
BG480330 choriocarcinoma, placenta STX16andNPEPL1.j 758 to 1373 1 to 615       615/615
(100 %)
3 diff
(99.6 %id)
BG333648 melanotic melanoma, skin STX16andNPEPL1.j 765 to 1465 1 to 707       707/897
(78 %)
18 diff
(98.0 %id)
CN401071 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 STX16andNPEPL1.j 782 to 1353 9 to 580       572/580
(98 %)
6 diff
(99.0 %id)
CN417683 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells STX16andNPEPL1.j 799 to 1488 1 to 689       689/689
(100 %)
1 diff
(99.9 %id)
DB105519 thymus STX16andNPEPL1.k 1 to 543 2 to 544   tiling clone, capped   543/543
(100 %)
1 diff
(99.9 %id)
CX759882 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass STX16andNPEPL1.k 38 to 536 18 to 517     Submitted on the opposite strand 500/736
(67 %)
17 diff
(97.7 %id)
AL833971 testis STX16andNPEPL1.k 91 to 4294 1 to 4203 exact tiling clone, available from DKFZ, AAA   4203/4203
(100 %)
5 diff
(99.9 %id)
DA043833 bladder STX16andNPEPL1.k 508 to 1068 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA880440 Prostate STX16andNPEPL1.k 697 to 1239 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BM718417 eye, fetal eye STX16andNPEPL1.k 917 to 1415 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BE088709 breast STX16andNPEPL1.k 927 to 1069 21 to 164       144/164
(87 %)
6 diff
(96.4 %id)
CD558107 testis STX16andNPEPL1.k 959 to 1799 1 to 852       852/871
(97 %)
20 diff
(97.8 %id)
CB153602 brain STX16andNPEPL1.k 1158 to 1706 1 to 550       550/550
(100 %)
2 diff
(99.7 %id)
AW860715 colon STX16andNPEPL1.k 1262 to 1404 15 to 158       144/171
(84 %)
8 diff
(95.4 %id)
DA079607 cerebellum STX16andNPEPL1.k 1273 to 1849 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
CN292794 embryonic stem cells, DMSO-treated H9 cellline STX16andNPEPL1.k 1374 to 1756 1 to 383       383/383
(100 %)
0 diff
(100 %id)
BE081574 breast STX16andNPEPL1.k 1421 to 1634 213 to 1     Submitted on the opposite strand 213/217
(98 %)
4 diff
(98.2 %id)
DA372685 thalamus STX16andNPEPL1.k 1450 to 2001 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
CU443238 epidermis STX16andNPEPL1.k 1589 to 1868 7 to 286       280/286
(97 %)
7 diff
(97.6 %id)
CU447124 epidermis STX16andNPEPL1.k 1589 to 2329 7 to 747       741/747
(99 %)
5 diff
(99.4 %id)
CU443091 epidermis STX16andNPEPL1.k 1840 to 2543 722 to 19     Submitted on the opposite strand 704/722
(97 %)
0 diff
(100 %id)
CU449486 epidermis STX16andNPEPL1.k 1840 to 2543 722 to 19     Submitted on the opposite strand 704/722
(97 %)
0 diff
(100 %id)
AX721181   STX16andNPEPL1.k 2302 to 3718 1 to 1429       1429/1429
(100 %)
8 diff
(99.5 %id)
AK126390 uterus STX16andNPEPL1.k 2621 to 4291 1 to 1670   tiling clone, available from FLJ,   1670/1670
(100 %)
5 diff
(99.8 %id)
DB253004 uterus STX16andNPEPL1.k 2622 to 3203 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DB078076 testis STX16andNPEPL1.k 3110 to 3617 2 to 509   capped   508/508
(100 %)
0 diff
(100 %id)
BE171397 head_neck STX16andNPEPL1.k 3534 to 3653 1 to 120       120/123
(97 %)
1 diff
(99.2 %id)
DB297882 cerebellum STX16andNPEPL1.k 3758 to 4294 537 to 1       537/537
(100 %)
3 diff
(99.5 %id)
BM683472 eye, fetal eye STX16andNPEPL1.k 4154 to 4294 160 to 19   AAA   142/142
(100 %)
2 diff
(98.6 %id)
CX755453 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass STX16andNPEPL1.l 1 to 636 43 to 678 E216K E223Q N225I L227* tiling clone, Submitted on the opposite strand 737/793
(92 %)
18 diff
(97.8 %id)
DA127666 cerebellum STX16andNPEPL1.m 1 to 568 2 to 569   tiling clone, capped   568/568
(100 %)
1 diff
(99.9 %id)
CR991155 T-Lymphocytes STX16andNPEPL1.m 260 to 946 1 to 688       688/688
(100 %)
1 diff
(99.9 %id)
CR986291 T-Lymphocytes STX16andNPEPL1.m 329 to 1114 1 to 789   tiling clone,   789/790
(99 %)
3 diff
(99.7 %id)
AF428146   STX16andNPEPL1.n 1 to 760 1 to 760 exact tiling clone,   760/760
(100 %)
1 diff
(99.9 %id)
BG035083 adenocarcinoma, cell line, Liver STX16andNPEPL1.n 21 to 797 1 to 771   tiling clone,   771/952
(80 %)
25 diff
(97.4 %id)
BF922206 nervous_tumor STX16andNPEPL1.n 739 to 1295 569 to 13   tiling clone, Submitted on the opposite strand 557/569
(97 %)
1 diff
(99.9 %id)
BF351760 head_neck STX16andNPEPL1.n 891 to 1023 11 to 139       129/149
(86 %)
6 diff
(96.0 %id)
CV571745 cornea, eye STX16andNPEPL1.o 1 to 555 1 to 555   tiling clone,   555/555
(100 %)
0 diff
(100 %id)
CN259745 embryonic stem cells, cell lines H1, H7, andH9 STX16andNPEPL1.o 187 to 768 1 to 581   tiling clone,   581/581
(100 %)
2 diff
(99.7 %id)
AL555285 placenta STX16andNPEPL1.p 1 to 875 1 to 871   tiling clone,   871/871
(100 %)
9 diff
(99.0 %id)
BP370076 testis STX16andNPEPL1.p 317 to 894 1 to 579   tiling clone,   579/579
(100 %)
6 diff
(99.0 %id)
BQ671118 epidermoid carcinoma, cell line, salivary gland STX16andNPEPL1.p 914 to 1820 1 to 907   tiling clone,   907/907
(100 %)
4 diff
(99.6 %id)
BQ669280 epidermoid carcinoma, cell line, salivary gland STX16andNPEPL1.p 914 to 1721 1 to 820       783/916
(85 %)
17 diff
(98.2 %id)
BQ668589 epidermoid carcinoma, cell line, salivary gland STX16andNPEPL1.p 914 to 1853 1 to 940       940/948
(99 %)
19 diff
(98.0 %id)
BM046974 carcinoma, cell line, Prostate STX16andNPEPL1.p 1252 to 2079 1 to 828       828/831
(99 %)
13 diff
(98.5 %id)
BM047787 carcinoma, cell line, Prostate STX16andNPEPL1.p 1252 to 2015 1 to 762   available from MGC,   762/762
(100 %)
9 diff
(98.9 %id)
BC068074 Prostate, carcinoma STX16andNPEPL1.p 1253 to 2607 1 to 1355   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1355/1355
(100 %)
2 diff
(99.9 %id)
BQ952493 carcinoma, cell line, Prostate STX16andNPEPL1.p 1255 to 2098 1 to 842       842/1031
(81 %)
18 diff
(98.3 %id)
BQ939471 carcinoma, cell line, Prostate STX16andNPEPL1.p 1255 to 1906 1 to 661       661/1407
(46 %)
32 diff
(97.8 %id)
BU509375 leiomyosarcoma, uterus STX16andNPEPL1.p 1274 to 2179 1 to 910       910/913
(99 %)
17 diff
(98.2 %id)
CD108701 brain, Pituitary STX16andNPEPL1.p 1278 to 2145 1 to 874       874/878
(99 %)
14 diff
(98.5 %id)
BQ380210 uterus_tumor STX16andNPEPL1.p 1377 to 1710 17 to 351       335/351
(95 %)
8 diff
(97.8 %id)
BQ362058 ovary STX16andNPEPL1.p 1427 to 1799 375 to 3       373/375
(99 %)
0 diff
(100 %id)
BG315196   STX16andNPEPL1.p 1451 to 1747 1 to 297       297/297
(100 %)
3 diff
(99.0 %id)
AK096873 salivary gland STX16andNPEPL1.p 1509 to 2797 1 to 1289   available from FLJ,   1289/1289
(100 %)
3 diff
(99.8 %id)
DA892607 salivary gland STX16andNPEPL1.p 1510 to 2348 2 to 836   capped   835/836
(99 %)
13 diff
(98.5 %id)
AA452772   STX16andNPEPL1.p 1521 to 1799 1 to 279       279/279
(100 %)
0 diff
(100 %id)
BE092793 breast STX16andNPEPL1.p 1708 to 2043 345 to 7     Submitted on the opposite strand 339/345
(98 %)
0 diff
(100 %id)
BF800114 colon_ins STX16andNPEPL1.p 1797 to 2244 462 to 16     Submitted on the opposite strand 447/462
(96 %)
0 diff
(100 %id)
AL704756 human skeletal muscle STX16andNPEPL1.p 1901 to 2502 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
CA313861 Human Lung Epithelial cells, lung STX16andNPEPL1.p 1903 to 2610 723 to 16   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 708/708
(100 %)
1 diff
(99.9 %id)
AA344951 gall bladder STX16andNPEPL1.p 2059 to 2351 1 to 293       293/293
(100 %)
0 diff
(100 %id)
AW963223   STX16andNPEPL1.p 2073 to 2780 1 to 708   tiling clone,   708/712
(99 %)
5 diff
(99.3 %id)
AA864964 Kidney, kidney tumor STX16andNPEPL1.p 2116 to 2606 491 to 1       491/491
(100 %)
1 diff
(99.8 %id)
AA300147 uterus STX16andNPEPL1.p 2144 to 2456 1 to 313       313/313
(100 %)
1 diff
(99.7 %id)
AW262844 brain, three pooled meningiomas STX16andNPEPL1.p 2155 to 2607 453 to 1       453/453
(100 %)
0 diff
(100 %id)
AI269366 Kidney STX16andNPEPL1.p 2210 to 2610 401 to 1       401/401
(100 %)
3 diff
(99.3 %id)
AW613530 carcinoid, lung STX16andNPEPL1.p 2224 to 2732 1 to 508     Submitted on the opposite strand 508/508
(100 %)
7 diff
(98.7 %id)
AI292094 carcinoid, lung STX16andNPEPL1.p 2242 to 2679 1 to 437     Submitted on the opposite strand 437/437
(100 %)
3 diff
(99.4 %id)
AI927947 Kidney STX16andNPEPL1.p 2291 to 2828 544 to 8       537/544
(98 %)
0 diff
(100 %id)
BF593717 brain, glioblastoma (pooled) STX16andNPEPL1.p 2316 to 2829 514 to 1       514/514
(100 %)
0 diff
(100 %id)
BF511340   STX16andNPEPL1.p 2350 to 2828 500 to 23       478/500
(95 %)
0 diff
(100 %id)
AI338996 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus STX16andNPEPL1.p 2385 to 2797 424 to 12   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 413/413
(100 %)
1 diff
(99.8 %id)
AI423904 brain, glioblastoma (pooled) STX16andNPEPL1.p 2386 to 2829 444 to 1       444/444
(100 %)
0 diff
(100 %id)
BX099540 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus STX16andNPEPL1.p 2406 to 2828 441 to 20       422/441
(95 %)
0 diff
(100 %id)
AI278182 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus STX16andNPEPL1.p 2417 to 2828 423 to 13       411/423
(97 %)
0 diff
(100 %id)
AI097244 brain, glioblastoma (pooled) STX16andNPEPL1.p 2423 to 2836 418 to 5       414/418
(99 %)
0 diff
(100 %id)
BQ723000 sympathetic trunk STX16andNPEPL1.p 2439 to 3090 1 to 657       657/926
(70 %)
8 diff
(99.2 %id)
AI123143 heart STX16andNPEPL1.p 2489 to 2828 347 to 9       339/347
(97 %)
0 diff
(100 %id)
BF243303 bone marrow, from acute myelogenous leukemia STX16andNPEPL1.p 2534 to 3224 1 to 685       685/894
(76 %)
14 diff
(98.5 %id)
AL577823 placenta STX16andNPEPL1.p 2547 to 3437 897 to 8   tiling clone,   890/897
(99 %)
0 diff
(100 %id)
AI468704 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus STX16andNPEPL1.p 2583 to 2835 271 to 19   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 253/253
(100 %)
0 diff
(100 %id)
AI758293 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus STX16andNPEPL1.p 2630 to 2828 205 to 7       199/205
(97 %)
0 diff
(100 %id)
BU633023 cell lines, Chondrosarcoma STX16andNPEPL1.p 2786 to 3494 727 to 19   AAA   709/709
(100 %)
2 diff
(99.8 %id)
BI333534 cervical carcinoma cell line, cervix STX16andNPEPL1.p 2790 to 3465 1 to 674       674/674
(100 %)
3 diff
(99.6 %id)
BI497302 cochlea, ear STX16andNPEPL1.p 2871 to 3494 1 to 624   AAA   624/624
(100 %)
6 diff
(99.1 %id)
BM126543 Islets of Langerhans, Pancreas STX16andNPEPL1.p 2880 to 3377 1 to 498       498/498
(100 %)
4 diff
(99.2 %id)
AW082229 pooled STX16andNPEPL1.p 2968 to 3494 527 to 1   tiling clone,   527/527
(100 %)
0 diff
(100 %id)
AW418945 2 pooled tumors (clear cell type), Kidney STX16andNPEPL1.p 3001 to 3496 497 to 2       496/497
(99 %)
0 diff
(100 %id)
DB545004 hippocampus STX16andNPEPL1.p 3002 to 3494 1 to 493     Submitted on the opposite strand 493/493
(100 %)
8 diff
(98.4 %id)
AA886300 Kidney STX16andNPEPL1.p 3010 to 3500 494 to 2       493/494
(99 %)
0 diff
(100 %id)
DB547977 hippocampus STX16andNPEPL1.p 3023 to 3494 1 to 472     Submitted on the opposite strand 472/472
(100 %)
0 diff
(100 %id)
AI860664 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors STX16andNPEPL1.p 3042 to 3494 467 to 15   AAA   453/453
(100 %)
5 diff
(98.9 %id)
AW073691 2 pooled high-grade transitional celltumors, genitourinary tract STX16andNPEPL1.p 3069 to 3489 437 to 17   AAA   421/421
(100 %)
2 diff
(99.6 %id)
AW294505   STX16andNPEPL1.p 3085 to 3494 427 to 18   AAA   410/410
(100 %)
1 diff
(99.8 %id)
AW078651 2 pooled high-grade transitional celltumors, genitourinary tract STX16andNPEPL1.p 3088 to 3489 418 to 17   AAA   402/402
(100 %)
3 diff
(99.3 %id)
BE465175 Kidney STX16andNPEPL1.p 3103 to 3494 396 to 5       392/396
(98 %)
0 diff
(100 %id)
AA960975 pooled STX16andNPEPL1.p 3118 to 3494 377 to 1       377/377
(100 %)
0 diff
(100 %id)
AW301582 Kidney STX16andNPEPL1.p 3139 to 3494 356 to 1       356/356
(100 %)
0 diff
(100 %id)
AA608871   STX16andNPEPL1.p 3145 to 3496 353 to 2   tiling clone,   352/353
(99 %)
0 diff
(100 %id)
AI445809 poorly differentiated adenocarcinoma withsignet ring cell features, stomach STX16andNPEPL1.p 3177 to 3500 325 to 2       324/325
(99 %)
0 diff
(100 %id)
AK316547   STX16andNPEPL1.q 1 to 1119 1 to 1119 exact tiling clone,   1119/1119
(100 %)
3 diff
(99.8 %id)
DC424825   STX16andNPEPL1.q 1 to 804 1 to 800 exact     800/826
(96 %)
10 diff
(98.8 %id)
CN417678 embryonic stem cells, cell lines H1, H7, andH9 STX16andNPEPL1.q 240 to 801 7 to 568       562/568
(98 %)
7 diff
(98.8 %id)
AK296282 thalamus STX16andNPEPL1.q 281 to 1123 1 to 843   tiling clone,   843/843
(100 %)
0 diff
(100 %id)
BF096123 uterus_tumor STX16andNPEPL1.q 281 to 784 503 to 1       503/515
(97 %)
6 diff
(98.9 %id)
DC341840 thalamus STX16andNPEPL1.q 281 to 852 1 to 572       572/572
(100 %)
0 diff
(100 %id)
CN417685 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 STX16andNPEPL1.q 295 to 1113 1 to 833       833/890
(93 %)
34 diff
(96.2 %id)
DC427581   STX16andNPEPL1.q 2690 to 3259 575 to 1   tiling clone,   575/577
(99 %)
18 diff
(96.9 %id)
BE536701 cervix STX16andNPEPL1.r 1 to 623 1 to 626 K111T K112E N113R R114I K115G ... tiling clone,   626/657
(95 %)
9 diff
(98.7 %id)
BQ229292 embryonal carcinoma, cell line, testis STX16andNPEPL1.s 1 to 850 1 to 858 exact tiling clone,   858/895
(95 %)
17 diff
(98.2 %id)
CT003761 T-Lymphocytes STX16andNPEPL1.t 1 to 737 1 to 739 S57X E80D I81L Q82X E114X ... tiling clone,   842/848
(99 %)
25 diff
(97.1 %id)
BY797853 eye STX16andNPEPL1.u 1 to 597 1 to 597 exact tiling clone,   597/597
(100 %)
0 diff
(100 %id)
CB960198 Human Placenta, placenta STX16andNPEPL1.va-u 1 to 648 28 to 680 exact     653/822
(79 %)
8 diff
(99.1 %id)
CF594260 Human Placenta, placenta STX16andNPEPL1.va-u 1 to 719 29 to 756 exact tiling clone,   728/864
(84 %)
13 diff
(98.5 %id)
TI_158432721   STX16andNPEPL1.va-u 9 to 674 751 to 85   AAA   667/878
(75 %)
12 diff
(98.7 %id)
CN417677 embryonic stem cells, cell lines H1, H7, andH9 STX16andNPEPL1.va-u 14 to 643 1 to 631       631/631
(100 %)
2 diff
(99.7 %id)
BQ707741 Spleen STX16andNPEPL1.va-u 24 to 731 8 to 721       714/892
(80 %)
12 diff
(98.7 %id)
CN417676 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells STX16andNPEPL1.va-u 25 to 520 1 to 496       496/496
(100 %)
1 diff
(99.8 %id)
CN417673 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells STX16andNPEPL1.va-u 30 to 696 1 to 668       668/668
(100 %)
3 diff
(99.6 %id)
BM008279 Spleen STX16andNPEPL1.va-u 31 to 668 1 to 640       640/681
(93 %)
14 diff
(98.0 %id)
TI_59382643   STX16andNPEPL1.va-u 31 to 578 61 to 619       559/676
(82 %)
17 diff
(97.5 %id)
TI_59383543   STX16andNPEPL1.va-u 31 to 668 104 to 743       640/681
(93 %)
14 diff
(98.0 %id)
BG259429 embryonal carcinoma, cell line, testis STX16andNPEPL1.va-u 32 to 881 1 to 846   tiling clone,   846/975
(86 %)
51 diff
(94.8 %id)
BQ890585 Spleen STX16andNPEPL1.va-u 35 to 757 1 to 730   tiling clone,   730/932
(78 %)
13 diff
(98.7 %id)
BU930967 ovary, teratocarcinoma, cell line STX16andNPEPL1.va-u 36 to 688 1 to 656       656/961
(68 %)
14 diff
(98.6 %id)
CN417681 embryonic stem cells, cell lines H1, H7, andH9 STX16andNPEPL1.va-u 49 to 507 1 to 459       459/459
(100 %)
0 diff
(100 %id)
TI_157609324   STX16andNPEPL1.va-u 56 to 674 724 to 97   AAA   628/1103
(56 %)
26 diff
(97.7 %id)
CN417680 embryonic stem cells, cell lines H1, H7, andH9 STX16andNPEPL1.va-u 67 to 554 1 to 488       488/488
(100 %)
1 diff
(99.8 %id)
BP396908 pancreatic islet STX16andNPEPL1.va-u 115 to 614 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
CF528596 placenta STX16andNPEPL1.va-u 256 to 674 436 to 18   AAA   419/419
(100 %)
0 diff
(100 %id)
CF529893 placenta STX16andNPEPL1.va-u 272 to 674 421 to 19   AAA   403/403
(100 %)
2 diff
(99.6 %id)
BG951916 colon STX16andNPEPL1.va-u 303 to 551 1 to 250       250/250
(100 %)
9 diff
(96.4 %id)
CB988338 Human Placenta, placenta STX16andNPEPL1.va-u 811 to 1490 21 to 702   tiling clone,   682/770
(88 %)
11 diff
(98.6 %id)
CB989387 Human Placenta, placenta STX16andNPEPL1.va-u 811 to 1338 21 to 558       538/861
(62 %)
17 diff
(98.1 %id)
BG567610 Liver STX16andNPEPL1.va-u 1132 to 1975 1 to 844   tiling clone,   844/848
(99 %)
31 diff
(96.4 %id)
AF008937   STX16andNPEPL1.vb 1 to 942 1 to 941 exact tiling clone,   941/941
(100 %)
2 diff
(99.8 %id)
BG773920 choriocarcinoma, placenta STX16andNPEPL1.vc 1 to 729 3 to 730 S65I tiling clone,   730/730
(100 %)
5 diff
(99.4 %id)
DA902019   STX16andNPEPL1.vd 1 to 571 2 to 572 exact tiling clone, capped   571/571
(100 %)
0 diff
(100 %id)
CK905391 insulinoma, Pancreas STX16andNPEPL1.ve 1 to 528 547 to 20 exact tiling clone, Submitted on the opposite strand 528/547
(96 %)
0 diff
(100 %id)
BM509348 insulinoma, Pancreas STX16andNPEPL1.ve 23 to 528 525 to 20   tiling clone, Submitted on the opposite strand 506/525
(96 %)
6 diff
(98.9 %id)
BU070881 insulinoma, Pancreas STX16andNPEPL1.ve 57 to 528 491 to 20     Submitted on the opposite strand 472/491
(96 %)
0 diff
(100 %id)
AA479585 ovarian tumor, ovary STX16andNPEPL1.ve 211 to 504 12 to 303   fully sequenced,   292/303
(96 %)
6 diff
(98.1 %id)
BE774653 uterus STX16andNPEPL1.ve 221 to 510 1 to 293       293/293
(100 %)
17 diff
(94.2 %id)
AA477424 ovarian tumor, ovary STX16andNPEPL1.ve 278 to 522 243 to 1   tiling clone, fully sequenced,   243/243
(100 %)
2 diff
(99.2 %id)
AA640186 normal prostate, Prostate STX16andNPEPL1.ve 285 to 521 254 to 18   AAA   237/237
(100 %)
2 diff
(99.2 %id)
BU860316 adenocarcinoma, cell line, breast STX16andNPEPL1.ve 292 to 528 1 to 237   tiling clone, AAA   237/237
(100 %)
5 diff
(97.9 %id)
BE881951 leiomyosarcoma, uterus STX16andNPEPL1.ve 350 to 526 1 to 178       178/197
(90 %)
3 diff
(98.5 %id)
BF958366 nervous_normal STX16andNPEPL1.vf-u 1 to 228 233 to 6 S2P tiling clone,   228/246
(92 %)
0 diff
(100 %id)
BE246533 leukopheresis STX16andNPEPL1.vf-u 20 to 418 400 to 1       400/400
(100 %)
5 diff
(98.8 %id)
BE245863 leukopheresis STX16andNPEPL1.vf-u 119 to 418 299 to 1       299/299
(100 %)
11 diff
(96.4 %id)
BX644835   STX16andNPEPL1.vf-u 182 to 1013 1 to 828   tiling clone,   828/828
(100 %)
6 diff
(99.3 %id)
BM450515 eye, retinoblastoma STX16andNPEPL1.vg 1 to 940 1 to 948 L45R N65K E66* tiling clone,   948/1075
(88 %)
25 diff
(97.7 %id)
BX504481   STX16andNPEPL1.vh 1 to 712 1 to 713 exact tiling clone,   713/717
(99 %)
4 diff
(99.5 %id)
BG623578 placenta STX16andNPEPL1.vi-u 1 to 649 1 to 647 C21A S22A R23G W24G K25R ... tiling clone,   647/647
(100 %)
4 diff
(99.4 %id)
DC349225   STX16andNPEPL1.vj 1 to 577 1 to 577 exact tiling clone,   577/577
(100 %)
0 diff
(100 %id)
DB469688 hippocampus STX16andNPEPL1.vj 13 to 462 1 to 452       452/452
(100 %)
38 diff
(91.6 %id)
DB261527 uterus STX16andNPEPL1.vk 1 to 576 2 to 576 D91T M92W A93P T94P L95* tiling clone, capped   575/575
(100 %)
2 diff
(99.7 %id)
BM688944 eye, optic nerve STX16andNPEPL1.vl-u 1 to 220 213 to 432   tiling clone, fully sequenced,   220/432
(50 %)
6 diff
(98.7 %id)
BE246495 leukopheresis STX16andNPEPL1.vl-u 63 to 440 1 to 378   tiling clone,   378/378
(100 %)
5 diff
(98.7 %id)
BM662618 eye, optic nerve STX16andNPEPL1.vl-u 201 to 568 384 to 19 S34F tiling clone, fully sequenced, AAA   366/366
(100 %)
3 diff
(99.2 %id)
DA158295 amygdala STX16andNPEPL1.vm 1 to 555 6 to 560 E70G tiling clone, capped   559/559
(100 %)
1 diff
(99.9 %id)
DA200346 brain STX16andNPEPL1.vm 1 to 534 2 to 535   tiling clone, capped   534/534
(100 %)
2 diff
(99.7 %id)
DB159072 thymus STX16andNPEPL1.vn-u 1 to 553 2 to 554 S85N tiling clone, capped   553/553
(100 %)
2 diff
(99.7 %id)
DA188445 amygdala STX16andNPEPL1.vo 1 to 552 2 to 553 exact tiling clone, capped   552/552
(100 %)
0 diff
(100 %id)
BM011602 brain, neuroblastoma, cell line STX16andNPEPL1.vp 1 to 526 1 to 538 P4R R6G Q7R A8R L9W ... tiling clone,   538/539
(99 %)
29 diff
(94.7 %id)
TI_59380772   STX16andNPEPL1.vp 2 to 526 118 to 654 P4R R6G Q7R A8R L9W ...     537/538
(99 %)
28 diff
(94.8 %id)
DA326248 hippocampus STX16andNPEPL1.vq 1 to 506 2 to 507 exact tiling clone, capped   506/506
(100 %)
0 diff
(100 %id)
AB075854.
matches multiple genes
brain Gene sutora, variant not shown       available from KIAA, This clone was ignored, also hits gene sutora    
AB075854.
matches multiple genes
brain Gene STX16andNPEPL1, variant not shown       available from KIAA, This clone was ignored, also hits gene sutora    
AK304867 uterus Gene STX16andNPEPL1, variant not shown         Suspected internal deletion, this clone was ignored    
AV683744 hepatocellular carcinoma Gene STX16andNPEPL1, variant not shown         Suspected internal deletion, this clone was ignored    
BM794658 Ascites, stomach Gene STX16andNPEPL1, variant not shown         Submitted on the opposite strand    
DB001433 breast, tumor tissue Gene STX16andNPEPL1, variant not shown       capped      
DB335192 breast, tumor tissue Gene STX16andNPEPL1, variant not shown              
CN478629 Human Lung Epithelial cells, lung Gene STX16andNPEPL1, variant not shown         Submitted on the opposite strand    
87 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va-u, .vb, .vc, .vd, .ve, .vf-u, .vg, .vh, .vi-u, .vj, .vk, .vl-u, .vm, .vn-u, .vo, .vp, .vq, .vr-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI